Literature DB >> 12668442

Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.

David C Reeves1, Muhammed F R Sayed, Pak-Lee Chau, Kerry L Price, Sarah C R Lummis.   

Abstract

5-HT(3) receptors demonstrate significant structural and functional homology to other members of the Cys-loop ligand-gated ion channel superfamily. The extracellular domains of these receptors share similar sequence homology (approximately 20%) with Limnaea acetylcholine binding protein, for which an x-ray crystal structure is available. We used this structure as a template for computer-based homology modeling of the 5-HT(3) receptor extracellular domain. AutoDock software was used to dock 5-HT into the putative 5-HT(3) receptor ligand-binding site, resulting in seven alternative energetically favorable models. Residues located no more than 5 A from the docked 5-HT were identified for each model; of these, 12 were found to be common to all seven models with five others present in only certain models. Some docking models reflected the cation-pi interaction previously demonstrated for W183, and data from these and other studies were used to define our preferred models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668442      PMCID: PMC1302800          DOI: 10.1016/S0006-3495(03)75039-5

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  30 in total

1.  Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits.

Authors:  N Unwin; A Miyazawa; J Li; Y Fujiyoshi
Journal:  J Mol Biol       Date:  2002-06-21       Impact factor: 5.469

2.  Distinct agonist- and antagonist-binding sites on the glycine receptor.

Authors:  R J Vandenberg; C A Handford; P R Schofield
Journal:  Neuron       Date:  1992-09       Impact factor: 17.173

3.  Automated docking of substrates to proteins by simulated annealing.

Authors:  D S Goodsell; A J Olson
Journal:  Proteins       Date:  1990

4.  SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Authors:  N Guex; M C Peitsch
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

5.  Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding site.

Authors:  J E Gready; S Ranganathan; P R Schofield; Y Matsuo; K Nishikawa
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

6.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

7.  Cation-pi interactions in structural biology.

Authors:  J P Gallivan; D A Dougherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

8.  Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.

Authors:  Darren L Beene; Gabriel S Brandt; Wenge Zhong; Niki M Zacharias; Henry A Lester; Dennis A Dougherty
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

9.  Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine.

Authors:  Matthieu Schapira; Ruben Abagyan; Maxim Totrov
Journal:  BMC Struct Biol       Date:  2002-01-18

10.  Identification of critical residues in loop E in the 5-HT3ASR binding site.

Authors:  Padmavati Venkataraman; Srinivasan P Venkatachalan; Prasad R Joshi; Mani Muthalagi; Marvin K Schulte
Journal:  BMC Biochem       Date:  2002-06-13       Impact factor: 4.059

View more
  28 in total

1.  Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Authors:  M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

2.  Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.

Authors:  A J Thompson; P-L Chau; S L Chan; S C R Lummis
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

Review 3.  Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region.

Authors:  Mariana Bartos; Jeremías Corradi; Cecilia Bouzat
Journal:  Mol Neurobiol       Date:  2009-10-28       Impact factor: 5.590

4.  Investigating the putative binding-mode of GABA and diazepam within GABA A receptor using molecular modeling.

Authors:  Suqin Ci; Tianrui Ren; Zhiguo Su
Journal:  Protein J       Date:  2008-02       Impact factor: 2.371

5.  A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.

Authors:  Stephan A Pless; Ariele P Hanek; Kerry L Price; Joseph W Lynch; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  Mol Pharmacol       Date:  2011-01-25       Impact factor: 4.436

6.  Tyrosine residues that control binding and gating in the 5-hydroxytryptamine3 receptor revealed by unnatural amino acid mutagenesis.

Authors:  Darren L Beene; Kerry L Price; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes.

Authors:  Jung-Hyun Na; Jaeil Shin; Yuna Jung; Dongbin Lim; Yeon-Kyun Shin; Yeon Gyu Yu
Journal:  Protein Expr Purif       Date:  2013-01-12       Impact factor: 1.650

Review 8.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Trans-cis switching mechanisms in proline analogues and their relevance for the gating of the 5-HT3 receptor.

Authors:  Claudio Melis; Giovanni Bussi; Sarah C R Lummis; Carla Molteni
Journal:  J Phys Chem B       Date:  2009-09-03       Impact factor: 2.991

Review 10.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.